2020/presente: Development and optimization of the diagnostic route for NTRK1, NTRK2 and NTRK3 fusion detection. Roche Farmacêutica Química, Lda. Coordenadora: Ana Carla Sousa

2023/2025: Iniciativa Molecular Diagnosis in Thyroid Cancer. Lilly Portugal, Produtos Farmacêuticos, Lda. Coordenadora: Ana Carla Sousa

2020/2023: Mutational Status of IGHv genes in CLL patients. Jansen/ Keypoint. Coordenadora: Sónia Matos

2020/2023: Clinical Trial in metastatic breast cancer (FOENIX-MBC2_TAS-120-201). Determination of high-level FGFR1 amplification and FGFR2 amplification by Fluorescence in Situ Hybridization (FISH). Taiho Oncology, inc./UBC. Coordenadora: Sónia Santos

2020/2022: Infogene, funded by Lisboa2020, Portugal2020 from European Regional Development Fund (FEDER). Coordenadora: Brígida Meireles

2017/2020: MyCardioGene test, funded by Lisboa2020, Portugal2020 from European Regional Development Fund (FEDER). Coordenadora: Ana Coutinho